Press Release

Clinical Ink CBO Jonathan Andrus Selected as DTRA Co-Leader Chosen to Head Decentralized Trials & Research Alliance Regulatory Gap Initiative

Horsham, Pa.; August 12, 2021 – Clinical Ink, a global clinical trial technology company, today announced that CBO Jonathan Andrus has been selected to co-lead …

Clinical Ink CBO Jonathan Andrus Selected as DTRA Co-Leader Chosen to Head Decentralized Trials & Research Alliance Regulatory Gap Initiative Read More…

Scroll to Top